≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Postinfectious hypothyroidism

DOID EFO Endpoint Browser PheWeb

E4_HYTHYPOSTINF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E03.3
  • Hospital discharge: ICD-9 — 2448A
  • Cause of death: ICD-10 — E03.3
  • Cause of death: ICD-9 — 2448A

2 out of 7 registries used, show all original rules.

204

4. Check minimum number of events

None

204

5. Include endpoints

None

204

6. Filter based on genotype QC (FinnGen only)

204

Control definitions (FinnGen only)

Control exclude
E4_THYROID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E03
Name in latin
Hypothyreosis postinfectiosa

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2062 1681 349
Only index persons 1434 1198 236
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.01
Only index persons 0.04 0.04 0.01
Median age at first event (years)
Whole population 55.61 56.08 52.28
Only index persons 48.62 49.33 45.03

-FinnGen-

Key figures

All Female Male
Number of individuals 204 170 34
Unadjusted period prevalence (%) 0.05 0.06 0.01
Median age at first event (years) 41.32 40.35 46.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
193
Matched controls
1930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
2237.1
231.1
184
17
104
Kela drug reimbursment
Thyroid insufficiency
2682.3
178.5
145
*
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
+∞
165.3
134
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1389.0
135.1
116
*
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
+∞
69.0
62
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
511.5
42.9
41
*
E03
ICD-10 Finland
Other hypothyroidism
146.5
35.0
36
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
399.5
34.0
33
*
A10AA02
ATC
NA
20.9
26.2
39
23
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
32.8
25.5
33
12
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
19.6
24.4
37
23
A10AA01
ATC
NA
24.0
24.0
34
17
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
10.2
23.6
49
62
A10AE04
ATC
insulin glargine; parenteral
9.8
22.6
48
63
T86
ICPC
Hypothyroidism/myxoedema
246.8
22.1
22
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
14.5
21.7
37
31
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
10.5
21.4
43
51
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
21.9
20.7
30
16
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
16.3
20.5
33
24
T89
ICPC
Diabetes insulin dependent
14.5
18.4
31
25
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
18.0
17
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
23.7
17.8
25
12
103
Kela drug reimbursment
Diabetes, insulin-treated
4.4
17.5
78
259
H04AA01
ATC
glucagon; nasal, parenteral
25.9
16.9
23
10
215
Kela drug reimbursment
Diabetes, non-insulin-treated
4.4
16.4
71
227
A10AE05
ATC
insulin detemir; parenteral
11.2
15.9
30
31
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
19.4
14.2
21
12
E03.8
ICD-10 Finland
Other specified hypothyroidism
+∞
13.7
13
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
13.6
13.0
22
18
E10
ICD-10 Finland
Type 1 diabetes mellitus
17.9
11.9
18
11
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
46.1
11.1
13
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
23.1
10.9
15
7
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
116.1
10.5
11
*
XCK10
NOMESCO Finland
Photography of fundus of eye
4.6
10.0
36
92
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
58.0
9.7
11
*
SPAT1262
SPAT
Handing over of treatment supplies
3.6
9.5
46
155
H3603, E103
ICD-10 Finland
NA
38.7
9.1
11
*
A12AA04
ATC
calcium carbonate; oral
52.4
8.8
10
*
A11CC03
ATC
alfacalcidol; systemic
35.0
8.2
10
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
8.0
7.9
17
23
A10AA03
ATC
NA
19.3
7.7
11
6
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
19.3
7.7
11
6
B03BA03
ATC
hydroxocobalamin; parenteral
6.1
7.6
20
36
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
7.5
67
330
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
7.3
7
*
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
+∞
7.3
7
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
21.0
7.2
10
5
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
12.7
7.2
12
10
E66.01
ICD-10 Finland
Obesity due to excess calories
4.7
7.0
23
54
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.2
7.0
16
24
107
Kela drug reimbursment
Pernicious anaemia
11.5
6.9
12
11
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
17.5
6.8
10
6
H3601, E113
ICD-10 Finland
NA
41.6
6.8
8
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
41.6
6.8
8
*
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
41.6
6.8
8
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
23.5
6.7
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
6.6
43
174
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.2
6.4
35
125
E06.3
ICD-10 Finland
Autoimmune thyroiditis
+∞
6.3
6
*
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
+∞
6.3
6
*
H3600, E103
ICD-10 Finland
NA
27.7
6.3
8
*
A10AE06
ATC
insulin degludec; parenteral
7.1
6.2
14
21
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.1
6.2
14
21
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
6.1
60
308
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
6.1
47
212

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
178
1250
4.33
12.47
10.1
2.6
pmol/l
16.5
14.5
14.28
168
1142
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
66
4.37
9.66
4.2
4.2
mmol/l
1.3
1.7
0.23
19
53
(3042936) Bacteria identified in Isolate by Culture
51
215
2.83
8.65
2.0
2.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
120
770
2.36
8.16
7.9
5.4
%
56.2
57.4
0.53
111
724
(3012516) Albumin [Mass/volume] in Urine
78
416
2.42
8.12
5.7
3.1
mg/l
856.5
366.7
0.27
54
248
(3002030) Lymphocytes/100 leukocytes in Blood
121
786
2.33
7.90
8.1
5.5
%
28.6
28.4
0.07
111
731
(3022096) Basophils/100 leukocytes in Blood
115
737
2.28
7.68
7.8
5.5
%
0.7
0.7
0.05
104
685
(3019069) Monocytes/100 leukocytes in Blood
118
770
2.26
7.47
8.5
5.7
%
9.1
8.2
2.53
109
724
(3019198) Lymphocytes [#/volume] in Blood
124
827
2.27
7.43
7.7
5.4
e9/l
1.8
1.9
0.38
114
737
(3020682) Albumin/Creatinine [Ratio] in Urine
79
441
2.29
7.26
7.2
3.9
mg/mmol
18.3
4.7
1.35
53
265
(3006504) Eosinophils/100 leukocytes in Blood
117
767
2.23
7.25
7.8
5.4
%
2.9
2.7
0.40
106
714
(3035637) Corticotropin [Mass/volume] in Plasma
10
14
7.46
6.76
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
91
552
2.17
6.71
2.9
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
120
811
2.16
6.69
7.5
5.4
e9/l
0.6
0.6
0.62
106
711
(3013115) Eosinophils [#/volume] in Blood
123
845
2.15
6.50
7.7
5.7
e9/l
0.2
0.2
0.21
110
757
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
116
787
2.10
6.25
11.2
5.6
mmol/l
1.2
1.2
1.30
95
672
(3006315) Basophils [#/volume] in Blood
119
816
2.10
6.22
7.6
5.4
e9/l
0.0
0.0
1.25
103
716
(3009508) Creatinine [Moles/volume] in Urine
76
441
2.15
6.17
5.8
2.9
mmol/l
6.3
6.8
0.52
65
365
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
628
2.08
6.12
2.0
1.9
pmol/l
109.2
96.1
1.19
48
302
(42870588) Differential panel, method unspecified - Blood
83
505
2.09
5.91
7.4
5.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
132
953
2.09
5.86
6.9
3.8
mmol/l
7.9
6.6
4.68
122
894
(3022313) Gas panel - Capillary blood
18
52
3.70
5.59
3.2
4.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
54
284
2.23
5.53
1.7
1.7
nmol/l
1341.1
1271.4
0.10
49
215
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
104
701
1.99
5.46
9.9
4.7
mmol/l
1.2
1.2
0.99
93
646
(3037467) Urinalysis macro (dipstick) panel - Urine
148
1144
2.07
5.09
6.3
4.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
28
4.49
4.89
2.7
2.9
u/ml
0.2
0.3
—
6
17
(3023368) Bacteria identified in Blood by Culture
68
409
1.99
4.83
4.4
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
101
695
1.90
4.80
3.0
2.2
nmol/l
73.8
77.4
0.70
93
631
(3007853) Bacteria identified in Skin by Aerobe culture
37
179
2.30
4.57
2.1
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
954
1.88
4.48
9.1
9.2
e9/l
4.2
4.2
0.00
116
840
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
347
1.99
4.42
1.9
1.7
pmol/l
2005.6
465.9
0.49
49
296
(4146454)
8
10
8.27
4.10
2.4
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
179
1534
2.36
4.08
11.8
3.5
mu/l
1.7
1.9
0.20
168
1404
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
157
1283
1.97
4.05
9.4
6.9
u/l
82.9
77.5
0.55
151
1203
(3021960) Folate [Moles/volume] in Serum or Plasma
60
365
1.91
4.03
1.7
1.5
nmol/l
17.9
22.0
1.93
53
317
(3019225) pH of Specimen
29
134
2.36
3.96
6.1
4.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
55
328
1.93
3.91
1.5
1.3
g/l
2.2
2.4
0.26
30
201
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
575
1.78
3.85
4.6
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
74
492
1.79
3.71
2.4
2.0
u/l
100.5
198.7
1.76
69
461
(3009261) Glucose [Presence] in Urine by Test strip
113
850
1.74
3.67
4.4
3.9
estimate
0.0
0.0
0.50
20
153
(3032080) INR in Blood by Coagulation assay
88
619
1.74
3.62
5.4
9.0
inr
1.2
1.2
0.21
22
190
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
92
657
1.73
3.57
4.5
4.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
10
7.20
3.39
2.7
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
130
2.24
3.36
5.1
4.7
%
1.1
0.7
—
7
40
(3021601) Nitrite [Presence] in Urine by Test strip
110
839
1.68
3.26
6.0
5.4
estimate
0.0
0.0
0.40
21
161
(3035350) Ketones [Presence] in Urine by Test strip
109
833
1.66
3.17
4.1
4.0
estimate
0.0
0.0
0.00
21
162
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
178
2.02
3.09
5.8
4.4
%
36.0
32.4
0.97
25
111
(36660697) Celiac disease serology panel - Serum
25
121
2.22
3.08
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
56
360
1.77
3.08
1.4
1.2
u/ml
0.9
2.1
—
6
101
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
87
632
1.66
3.06
3.7
3.7
ng/l
51.0
31.1
0.45
56
425
(3021440) Promyelocytes/100 leukocytes in Blood
25
122
2.20
3.02
5.0
4.9
%
0.0
0.1
—
6
36
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
102
2.30
2.99
2.1
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
17
4.85
2.95
1.6
1.1
—
—
—
0
0
(3013512) EKG study
66
450
1.69
2.93
4.3
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
50
316
1.77
2.90
2.9
2.8
mosm/kgh2o
506.3
533.1
0.34
41
266
(3037522) Nuclear Ab [Titer] in Serum
40
238
1.85
2.82
1.6
1.3
titre
416.0
466.7
—
10
48
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
37
3.09
2.73
1.0
1.1
—
3.0
—
0
8
(3041096) Erythrocytes [Presence] in Urine by Automated
68
477
1.64
2.68
3.9
3.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
92
696
1.59
2.65
7.0
3.5
g/l
34.8
35.8
0.89
86
651
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
38
3.00
2.62
6.9
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
236
1.81
2.60
2.4
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
344
1.69
2.55
3.0
2.4
e6/l
6.7
5.9
0.14
44
301
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
26
3.57
2.51
1.9
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
33
192
1.86
2.49
1.7
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
147
1253
1.62
2.45
6.8
4.2
mm/h
13.2
11.6
0.86
133
1157
(3012544) pH of Venous blood
27
149
1.94
2.38
6.4
3.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
35
2.95
2.34
5.3
2.2
mmol/l
24.3
25.9
—
10
27
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
18
3.99
2.27
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
61
432
1.59
2.27
5.1
6.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
29
3.20
2.25
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
48
2.59
2.23
4.5
2.9
g/l
0.4
0.1
—
7
16
(3021901) Oxygen saturation in Capillary blood
8
24
3.43
2.20
4.5
1.9
—
—
—
0
0
(4268621)
6
14
4.38
2.16
2.2
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
163
0.35
2.12
1.3
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
69
2.27
2.10
16.9
7.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
49
335
1.61
2.09
1.6
1.3
iu/ml
24.9
32.6
0.24
17
112
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
55
387
1.58
2.09
1.7
1.6
mg/l
0.9
1.1
0.57
41
310
(3015736) pH of Urine
85
659
1.50
2.07
3.8
3.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
119
1.95
2.06
4.3
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
61
441
1.55
2.05
3.9
2.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
15
4.09
2.05
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
38
2.72
2.04
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
90
710
1.48
1.99
11.1
9.5
e9/l
0.0
0.0
0.01
75
584
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
20
106
1.98
1.99
8.7
3.0
ng/l
149.7
78.3
0.84
15
97
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
21
3.41
1.98
2.4
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
93
740
1.47
1.97
4.3
2.6
ug/l
69.0
87.6
1.66
88
682
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
33
2.81
1.95
1.4
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
44
298
1.61
1.95
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
485
1.50
1.88
5.9
3.1
ph
7.4
7.4
—
9
95
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
35
2.64
1.82
1.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
60
2.25
1.82
2.9
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
180
1.71
1.79
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
65
490
1.48
1.77
3.8
2.9
e6/l
34.3
82.2
0.72
52
372
(3001019) Free T4 and TSH panel - Serum or Plasma
18
96
1.96
1.77
1.8
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
183
1692
1.79
1.77
25.8
14.7
mmol/l
139.0
139.7
2.69
177
1647
(3004616) Nuclear Ab [Presence] in Serum
6
18
3.40
1.76
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
61
2.21
1.75
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
323
1.55
1.75
1.5
1.3
u/ml
4.7
10.2
0.73
19
127
(40768443) Skin Pathology biopsy report
14
68
2.14
1.75
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
13
3.91
1.72
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
54
394
1.50
1.72
6.4
4.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
256
1.60
1.72
4.1
2.6
e6/l
2.1
1.2
0.32
24
139
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
182
1683
1.75
1.72
22.3
13.2
mg/l
21.8
22.4
0.08
158
1313
(3019150) Specific gravity of Urine by Refractometry
51
368
1.51
1.71
4.5
4.2
kg/l
1.0
1.0
0.32
12
55
(3030467) Casts [#/volume] in Urine by Automated count
61
457
1.48
1.71
4.0
2.8
e6/l
0.6
0.4
0.31
49
334
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
83
2.01
1.70
2.4
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
43
2.39
1.63
1.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
92
1.92
1.61
10.4
4.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
20
3.06
1.59
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
456
1.45
1.55
4.8
4.2
estimate
0.0
0.0
0.50
20
166
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.39
1.53
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
182
1695
1.68
1.51
26.0
14.6
mmol/l
4.0
4.0
0.95
176
1643
(3044640) Blood type and Crossmatch panel - Blood
67
523
1.42
1.50
2.5
2.1
—
—
—
0
0
(4094501)
9
38
2.43
1.47
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
142
1.70
1.46
3.8
2.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.78
1.44
1.0
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
89
1.87
1.42
7.6
4.4
mmol/l
26.0
25.1
0.39
16
89
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
41
2.25
1.39
1.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
41
2.25
1.39
2.4
2.0
mg/l
1.8
1.4
—
9
36
(3008295) Osmolality of Serum or Plasma
5
17
2.99
1.36
1.8
1.0
mosm/kgh2o
285.0
278.7
—
5
12
(3014576) Chloride [Moles/volume] in Serum or Plasma
28
187
1.58
1.33
11.0
5.8
mmol/l
104.4
103.8
0.28
28
182
(3018095) Leukocytes [#/volume] in Urine
73
589
1.37
1.32
4.6
3.5
e6/l
127.6
80.1
0.29
58
407
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
58
451
1.40
1.31
1.8
1.6
mmol/l
1.5
1.4
0.34
50
382
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
34
2.41
1.30
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
118
0.41
1.29
1.2
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
35
2.34
1.28
1.6
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
35
2.34
1.28
1.0
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
164
1.60
1.28
2.2
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
399
1.41
1.26
2.5
2.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
25
2.44
1.25
1.2
1.2
u/l
28.0
12.6
—
6
20
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
92
776
1.34
1.24
4.6
3.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
37
2.21
1.23
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
118
1.67
1.20
13.2
5.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
58
458
1.37
1.19
2.9
2.9
ng/l
1971.8
1171.1
0.43
48
390
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
287
1.44
1.19
6.1
3.4
ng/l
548.7
186.7
0.39
30
205
(3015377) Calcium [Moles/volume] in Serum or Plasma
70
571
1.34
1.17
2.7
3.1
mmol/l
2.3
2.4
0.89
62
502
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
236
1.48
1.16
4.0
2.8
e6/l
2.5
3.3
0.26
18
120
(3026493) Urate [Moles/volume] in Serum or Plasma
51
396
1.38
1.16
2.5
2.2
umol/l
344.0
6540.4
2.03
39
347
(4306422)
5
20
2.54
1.16
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
58
1.95
1.14
3.0
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
20
128
1.62
1.13
4.7
3.6
mmol/l
1.2
1.2
0.74
15
117
(3021788) Differential panel - Synovial fluid
7
30
2.38
1.13
1.1
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
161
1.56
1.13
2.1
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
97
1.70
1.10
1.3
1.2
iu/ml
128.1
112.3
—
9
34
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
41
1.99
1.10
1.4
1.3
mu/l
265.5
282.8
—
8
35
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
21
2.41
1.09
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
21
2.41
1.09
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.41
1.09
1.2
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
59
1.91
1.09
1.5
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
32
2.23
1.09
1.1
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
33
241
1.44
1.05
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
46
2.00
1.05
1.0
2.7
—
4.1
—
0
5
(3026389) Candida sp identified in Specimen by Organism specific culture
5
23
2.20
0.98
1.8
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
51
627
0.75
0.98
3.7
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
101
1.63
0.97
1.3
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
51
1.80
0.96
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
37
1.92
0.95
1.0
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
166
1556
1.36
0.92
20.3
12.1
ml/min/173m2
74.5
81.0
2.69
139
1268
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
29
2.10
0.90
1.2
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
6
31
1.96
0.85
4.0
1.5
g/l
136.5
129.8
—
6
21
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
89
1.62
0.83
4.5
2.5
%
1.4
1.1
0.71
14
89
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
46
1.77
0.83
3.5
4.3
mg/l
11.4
33.9
—
8
30
(3000330) Specific gravity of Urine by Test strip
14
90
1.60
0.80
3.4
4.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
33
1.84
0.79
2.7
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
164
1546
1.31
0.78
9.5
5.5
mmol/mol
46.5
39.3
7.67
153
1451
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
34
1.79
0.77
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
24
2.11
0.75
1.4
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
143
1.44
0.73
3.4
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
109
1.51
0.73
1.4
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
41
1.73
0.70
1.0
1.4
—
2.7
—
0
7
(40768804) Tissue Pathology biopsy report
79
693
1.23
0.70
2.0
2.0
—
—
—
0
0
(3020891) Body temperature
10
61
1.67
0.70
5.7
5.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
42
1.69
0.69
1.0
1.4
—
2.6
—
0
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
117
1070
1.22
0.69
3.6
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
28
1.80
0.66
1.8
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
28
1.80
0.66
4.6
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
28
1.80
0.66
1.8
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
29
1.74
0.64
1.6
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
157
1.38
0.62
1.3
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
30
1.68
0.62
1.4
2.1
e9/l
3.0
6.0
—
5
30
(3043409) Potassium [Moles/volume] in Arterial blood
8
51
1.59
0.61
3.6
5.1
mmol/l
4.2
3.9
—
8
46
(3014007) Fractional oxyhemoglobin in Arterial blood
14
97
1.48
0.61
12.4
6.7
%
93.4
94.1
0.18
14
97
(3039443) Prostate specific Ag panel - Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(4281824)
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
53
1.53
0.59
3.9
5.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
172
0.68
0.59
1.3
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
181
1746
1.33
0.58
20.9
12.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
159
1.36
0.58
2.0
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
204
1.31
0.57
1.8
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
36
1.69
0.57
2.3
2.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
55
1.47
0.57
1.5
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
99
1.44
0.56
1.4
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
38
1.60
0.55
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
170
1.33
0.54
1.3
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
99
0.59
0.53
1.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
40
1.51
0.52
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
245
1.26
0.50
1.7
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
84
1.46
0.50
2.0
2.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
13
93
1.42
0.49
14.4
7.8
mmol/l
23.0
24.8
0.70
13
87
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
94
1.41
0.47
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
148
1.31
0.45
2.1
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
51
1.39
0.44
3.9
3.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
93
0.63
0.43
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
31
1.63
0.43
1.4
2.7
%
52.2
64.8
—
5
31
(3044290) Cell count panel - Cerebral spinal fluid
5
32
1.58
0.42
1.2
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.3
—
3.7
—
0
16
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
36
1.40
0.38
1.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
90
1.35
0.36
1.7
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
18
221
0.80
0.35
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
43
380
1.17
0.35
4.9
3.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
182
1778
1.22
0.33
15.6
9.8
u/l
26.0
24.8
0.43
176
1723
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
53
1.33
0.31
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
163
0.78
0.31
1.5
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8
108
0.73
0.30
3.1
2.6
ug/l
0.5
0.9
—
8
60
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
9
73
1.24
0.26
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
35
314
1.14
0.24
2.5
2.5
mmol/l
2.4
2.5
0.27
29
271
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
147
0.80
0.24
6.1
4.6
%
21.4
21.8
—
7
71
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.2
—
47.1
—
0
6
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
15
125
1.22
0.23
2.9
2.3
—
5.5
—
0
5
(3049717) Cytology report of Urine Cyto stain
5
40
1.26
0.22
2.2
2.1
—
—
—
0
0
(3000492) Spirometry study
19
163
1.18
0.22
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
136
1402
0.91
0.22
27.1
16.0
%
13.8
13.7
0.80
130
1382
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
42
1.20
0.21
1.8
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.9
—
46.9
—
0
11
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.8
—
12.4
—
0
12
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
51
1.18
0.19
1.3
1.7
—
—
—
0
0
(4034850)
7
61
1.15
0.17
6.9
10.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
158
1.15
0.17
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
116
1125
1.07
0.16
4.3
2.7
u/l
71.9
41.9
1.50
108
1062
(40768793) Breast Pathology biopsy report
6
76
0.78
0.16
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
78
1.16
0.15
2.3
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
162
1648
0.92
0.15
6.3
4.1
mmol/l
1.6
1.6
0.11
148
1524
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
86
0.81
0.15
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
149
1519
0.93
0.14
25.0
13.8
%
37.4
39.4
1.20
101
1128
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
163
1653
0.93
0.12
6.3
4.2
mmol/l
4.6
4.8
1.53
153
1539
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
156
1584
0.94
0.12
5.8
3.8
mmol/l
1.3
1.2
0.56
144
1462
(4010399)
11
125
0.87
0.10
1.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
47
1.07
0.09
1.8
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
60
0.83
0.08
2.2
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
178
1764
1.07
0.08
26.4
15.3
umol/l
86.7
71.9
1.94
178
1764
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
142
0.91
0.06
2.9
2.9
ml/min/173m2
41.3
70.8
—
8
59
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
100
0.90
0.06
1.4
1.4
—
—
—
0
0
(4035726)
14
151
0.92
0.05
1.3
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
186
1849
1.07
0.05
33.3
19.5
e9/l
262.3
256.7
0.55
181
1812
(3044889) 12 lead EKG panel
117
1156
1.03
0.04
4.4
3.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
186
1851
1.06
0.03
33.2
19.6
e9/l
6.9
6.6
0.95
181
1805
(3026361) Erythrocytes [#/volume] in Blood
186
1851
1.06
0.03
33.3
19.5
e12/l
4.4
4.4
0.50
181
1806
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
168
1688
0.97
0.02
6.8
4.7
mmol/l
2.6
2.8
2.59
154
1559
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
353
1.02
0.01
1.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
426
0.98
0.00
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
162
1619
1.00
0.00
5.6
4.4
mmol/l
6.8
5.8
4.24
147
1487
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
195
0.97
0.00
6.4
7.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
12.9
—
0
6
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
19.9
—
0
8
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
115.8
—
0
8
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
9.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
139.8
—
0
6
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.9
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
5.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
120
1.00
0.00
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
28.0
—
0
9
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
4.6
—
46.2
—
0
9
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
9
0.00
0.00
0.0
1.0
—
172.5
—
0
9
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYTHYPOSTINF and mortality.

Females

Parameter HR [95% CI] p-value
E4_HYTHYPOSTINF 1.889 [1.3, 2.75] < 0.001
Birth year 0.995 [0.99, 1.0] 0.278

During the follow-up period (1.1.1998 — 31.12.2019), 115 out of 430 females with E4_HYTHYPOSTINF died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_HYTHYPOSTINF.

N-year risk Females Males
1 0.184% No data
5 1.234% No data
10 2.848% No data
15 5.051% No data
20 9.149% No data

Relationships between endpoints

↥

Index endpoint: E4_HYTHYPOSTINF – Postinfectious hypothyroidism

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data